Sign In
Buy CALA
Calithera Biosciences Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 10.85M and sold 6.41M CALA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
0 |
| ● Buy | 10.85M shares |
| ● Sell | 6.41M shares |
|
57% Buy Activity
Negligible or No Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jan 04, 2022 Sell |
Parlati Francesco Sr. Vp, Research |
18 077 Value: $11.9K |
||
|
Nov 11, 2021 Sell |
Orford Keith Director |
48 190 Value: $42.4K |
||
|
Nov 11, 2021 Sell |
Orford Keith Director |
48 190 Value: $42.4K |
||
|
Nov 10, 2021 Sell |
Orford Keith Director |
30 000 Value: $25.7K |
||
|
Nov 10, 2021 Sell |
Orford Keith Director |
30 000 Value: $25.7K |
||
|
Nov 10, 2021 Buy |
Molineaux Susan President & CEO |
100 000 Value: $84.7K |
||
|
Nov 10, 2021 Buy |
Drachman Jonathan G Director |
200 000 Value: $171.9K |
||
|
Nov 10, 2021 Buy |
Molineaux Christopher Sr. Vp, Development |
100 000 Value: $84.7K |
||
|
Nov 10, 2021 Buy |
Molineaux Christopher Sr. Vp, Development |
100 000 Value: $84.7K |
||
|
Nov 10, 2021 Buy |
Drachman Jonathan G Director |
200 000 Value: $171.9K |
||
|
Nov 10, 2021 Buy |
Molineaux Susan President & CEO |
100 000 Value: $84.7K |
||
|
Nov 09, 2021 Sell |
Orford Keith Director |
51 810 Value: $43.5K |
||
|
Nov 08, 2021 Sell |
Sjogren Eric Sr. Vp, Drug Discovery |
15 566 Value: $13.5K |
||
|
Nov 08, 2021 Sell |
Wong Stephanie See Remarks |
15 566 Value: $13.5K |
||
|
Nov 08, 2021 Sell |
Kuriakose Emil Chief Medical Officer |
3 077 Value: $3K |
||
|
Nov 08, 2021 Sell |
Parlati Francesco Sr. Vp, Research |
15 566 Value: $13.5K |
||
|
Nov 05, 2021 Buy |
Orford Keith Director |
30 000 Value: $0 |
||
|
Nov 05, 2021 Buy |
Molineaux Christopher Sr. Vp, Development |
12 000 Value: $0 |
||
|
Nov 05, 2021 Buy |
Sjogren Eric Sr. Vp, Drug Discovery |
30 000 Value: $0 |
||
|
Nov 05, 2021 Buy |
Wong Stephanie See Remarks |
30 000 Value: $0 |
||
|
Nov 05, 2021 Buy |
Ray Sumita See Remarks |
12 000 Value: $0 |
||
|
Nov 05, 2021 Buy |
Kuriakose Emil Chief Medical Officer |
12 000 Value: $0 |
||
|
Nov 05, 2021 Buy |
Parlati Francesco Sr. Vp, Research |
30 000 Value: $0 |
||
|
Oct 18, 2021 Buy |
Takeda Pharmaceutical Co Ltd 10 Percent Owner |
1 000 000 Value: $2.04M |
||
|
Oct 18, 2021 Buy |
Takeda Pharmaceutical Co Ltd 10 Percent Owner |
1 000 000 Value: $2.04M |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
